Featured Articles

  1. How A New Factory-In-A-Box Is Helping Scale Up Manufacturing Of Viral Vector Based Therapies To Reach More Patients 8/31/2018

    Manufacturing viral vector-based therapies such as vaccines and gene and cell therapies is complex, but a new manufacturing solution helps solve those challenges.

  2. FUJIFILM Diosynth Biotechnologies Drives Flexibility And Efficiency In Their Biomanufacturing Platform Using Integrated Automation 8/30/2018

    Through a successful implementation, FUJIFILM Diosynth was able to not only recognize the benefits that an integrated automation platform offers but also the importance of working with an experienced partner.

  3. Protein Analysis With Size Exclusion Chromatography (SEC) 2/20/2018

    This white paper presents fundamentals about analytical SEC and describes how our new-generation agarose-based SEC columns are used in analysis of biomolecules.

  4. Buffer Management Solutions For Large-Scale Biomanufacturing 2/1/2018

    How outsourcing and technologies such as in-line conditioning and in-line dilution can help prevent resource constraints, save time, and reduce manufacturing footprint and cost in buffer preparation.

  5. Expand Capacity In Buffer Management 2/1/2018

    Biomanufacturing requires large volumes of buffers, and preparation of these liquids can quickly become a bottleneck. Here, two options that can help intensify your large-scale buffer management are presented.

  6. How Biogen Integrated PAT With End-To-End Supply Chain Transparency

    To drive dependable critical process control requirements, Biogen explored novel strategies to increase process and raw material control and optimize communication of data throughout the supply chain.

  7. Add mRNA Capacity — Flexibly

    Learn about a platform that addresses five critical pain points to help mRNA manufacturers flexibly scale while improving the digital maturity of their sites.

  8. Research And Industry Join Forces As Modalities Merge

    How is current research driving the convergence of therapeutic modalities, and what implications does this have for patients and healthcare? Read on to find answers to these questions and more.

  9. Standardization And Flexibility In Aseptic Filling

    Standardization and flexibility in aseptic filling were thought to be mutually exclusive. But what if there was a standardized system with flexibility built into the aseptic process, so you didn’t have to choose?

  10. Unexpected SEC Results – Can It Be Improved?

    Sometimes, your size exclusion chromatography (SEC) results don’t look the way you want them to. Learn how to fix issues like poor resolution, peak tailing, and fronting from the tips shared in this FAQ.